Dankial-B 0.500Mg 2Ml With 5 Ampoules (Budesonide)

Category

Medication

Line

Inhalers

Brand

Dankial-B

Molecule

Budesonide

Presentation

0.500 mg, 2 mL, with 5 ampules

Laboratory

Dankel Medical

Indications

Dankial-B is indicated for the treatment of various respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). Budesonide, its active ingredient, acts as a corticosteroid that reduces inflammation in the airways, facilitating breathing and improving lung function. This medication is used as part of a therapeutic regimen that may include bronchodilators and other medications, according to medical evaluation. It is important to follow the prescribing physician's instructions to adjust the dose and frequency of use according to the patient's clinical response.

Composition

Each ampule of Dankial-B contains 0.500 mg of budesonide as the active ingredient. It also contains excipients that facilitate its administration by inhalation.

Contraindications

This medication is contraindicated in patients with known hypersensitivity to budesonide or any of the excipients in the formulation. Its use is not recommended in patients with untreated or active respiratory infections, or in those with fungal infections in the respiratory tract.

Precautions

Caution should be exercised in patients with pulmonary diseases, active or latent tuberculosis, as well as in those with a history of viral infections. Regular medical follow-up is essential to monitor treatment response and adjust therapy as needed. Prolonged use of corticosteroids may increase the risk of systemic adverse effects.

Storage

Store in a cool, dry place, protected from light and out of the reach of children. Do not use after the expiration date indicated on the packaging.

Consult your doctor.

Prescription required.